International Stem Cell Corporation
ISCO
$0.115
$0.02527.78%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 2.38% | 3.25% | -5.02% | -4.78% | 9.71% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.38% | 3.25% | -5.02% | -4.78% | 9.71% |
| Cost of Revenue | 5.30% | 2.41% | -3.68% | -2.69% | 20.43% |
| Gross Profit | 0.31% | 3.85% | -5.95% | -6.17% | 3.20% |
| SG&A Expenses | 4.62% | 2.98% | 4.47% | 1.52% | -5.74% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.62% | 5.11% | 2.64% | 1.06% | 4.26% |
| Operating Income | -205.06% | -44.36% | -309.22% | -262.30% | 68.61% |
| Income Before Tax | -293.71% | -595.65% | 12.64% | 60.42% | 149.65% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -293.71% | -595.65% | 12.64% | 60.42% | 149.65% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -293.71% | -595.65% | 12.64% | 60.42% | 149.65% |
| EBIT | -205.06% | -44.36% | -309.22% | -262.30% | 68.61% |
| EBITDA | -1,815.00% | -103.43% | -9,400.00% | -1,440.00% | 105.99% |
| EPS Basic | -593.20% | -521.19% | -9.46% | 36.80% | 116.70% |
| Normalized Basic EPS | -116.33% | -29.93% | -172.76% | -139.77% | 55.54% |
| EPS Diluted | -615.65% | -549.15% | -16.89% | 36.80% | 116.70% |
| Normalized Diluted EPS | -116.33% | -29.93% | -172.76% | -139.77% | 55.54% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | -0.03% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | -0.03% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
